GROWTH SOLUTION
GIGUERE CONSULTING connects law firms with pre-qualified mass tort claimants in real time validated, TCPA-compliant, and exclusive. Stop chasing prospects. Start signing clients.
High-Intent Claimant Leads
Exclusive & Never Shared
Verified Contact Details
Real-Time Lead Delivery
Precision Geographic Targeting
Scalable Intake Capacity
Full Lead Traceability
Consistent Client Pipeline
Understanding Mass Tort
Mass tort litigation involves large groups of plaintiffs who have each suffered similar harm caused by the same defendant typically a pharmaceutical company, manufacturer, or corporation. Unlike class actions, each plaintiff retains their individual case with separate damages.
These cases represent some of the highest-value legal opportunities in practice today. Successful mass tort settlements regularly reach hundreds of millions to billions of dollars, with individual plaintiff payouts ranging from tens of thousands to millions.
"The right mass tort lead can be worth more than 100 standard personal injury referrals. Quality sourcing and case qualification are everything.
GIGUERE CONSULTING sources mass tort claimants through targeted campaigns across our owned-and-operated platforms, ensuring every lead has expressed clear intent and meets case-specific qualification criteria before delivery to your firm.

Defective drugs, dangerous implants, recalled devices documented harm with clear causation and large plaintiff populations.

Contaminated water, toxic chemicals, industrial pollutants Camp Lejeune, Paraquat, PFAS, and similar cases.

Defective consumer products causing widespread injury talcum powder, CPAP machines, herbicides, and more.

NEC baby formula, contaminated infant products, and cases involving documented harm to premature infants and children.
Our Process
A proprietary four-step pipeline built for legal compliance, real-time speed,
and maximum case qualification.
In-house campaigns run across our owned platforms, search, and social targeting individuals who match mass tort exposure criteria for active dockets.
Claimants self-identify and complete qualification questions product used, duration of exposure, documented injury filtering for case-ready prospects only.
Every lead runs through our proprietary system: identity checks, TCPA consent documentation, duplicate removal, and full traceability certification.
Qualified leads reach your intake team in under 60 seconds via Ping Post, Live Transfer, or CRM integration while claimant intent is at its peak.
Active Campaigns
GIGUERE CONSULTING runs active acquisition campaigns for the highest-volume, highest-value mass tort dockets in the market today.

Non-Hodgkin's lymphoma linked to Roundup herbicide. One of the largest ongoing dockets with thousands of active plaintiffs and substantial settlement history.

Philips CPAP and BiPAP recall affecting millions of users. Linked to cancer and respiratory disease from degraded polyester foam particles in recalled devices.

Necrotizing enterocolitis (NEC) in premature infants linked to cow's milk-based formula from Mead Johnson and Abbott Laboratories.

Ovarian cancer and mesothelioma linked to talc-based products including Johnson & Johnson Baby Powder. Massive multi-billion dollar ongoing litigation.

Contaminated water at Camp Lejeune linked to cancer, Parkinson's, and other serious diseases in veterans and family members. Federal claims now open.

Paraquat herbicide exposure linked to Parkinson's disease. Emerging high-value docket with significant claimant population in agricultural regions.
Delivery Options
GIGUERE CONSULTING delivers mass tort leads in multiple formats to match your intake workflow and team structure.
Qualified claimant data delivered exclusively to your firm never sold to multiple buyers. You compete for cases, not for the same prospect against rival firms.
Real-time
Exclusive
CRM delivery
A pre-screened claimant is warm-transferred directly to your intake team while on the phone the highest-intent format available. They've just confirmed their interest.
Highest intent
Pre-screened
Our system pings your platform with lead data the moment a claimant qualifies enabling sub-60-second response times and maximum contact rates at scale.
API integration
Scalable
Why GIGUERE CONSULTING

Your mass tort leads go to your firm only never sold to multiple buyers. You compete for cases, not for the same claimant against five other firms.

Leads arrive the moment a claimant qualifies. Direct CRM integration means your intake team responds in under 60 seconds when intent is at its highest.

Every lead includes documented consent, traceable origin, and compliance certification. An auditable chain protects your firm on every contact.

Filter by state, injury type, product used, diagnosis, and exposure timeline. Receive only leads that match your firm's precise intake criteria.
Lead qualification rate
Contact rate in first 5 min
TCPA compliance rate
Avg. case value supported
Lead qualification rate